- Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis
-
Wang X, Liu X, Dang Z, Yu L, Jiang Y, Wang X, Yang Z
- KMID: 2508758
- Gut Liver.
- 2020 Mar;14(2):232-247.
- doi: 10.5009/gnl18546
Background/Aims: Studies have shown that nucleos(t)ide analogue (NA) treatment can reduce the risk of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients, but it is unclear which NA is... -
- CITED
-
- Close
- SHARE
-
- Close
